99 related articles for article (PubMed ID: 8058713)
1. Androgen receptor immunohistochemistry on paraffin-embedded tissue.
Loda M; Fogt F; French FS; Posner M; Cukor B; Aretz HT; Alsaigh N
Mod Pathol; 1994 Apr; 7(3):388-91. PubMed ID: 8058713
[TBL] [Abstract][Full Text] [Related]
2. Distant metastases from prostatic carcinoma express androgen receptor protein.
Hobisch A; Culig Z; Radmayr C; Bartsch G; Klocker H; Hittmair A
Cancer Res; 1995 Jul; 55(14):3068-72. PubMed ID: 7541709
[TBL] [Abstract][Full Text] [Related]
3. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor status of lymph node metastases from prostate cancer.
Hobisch A; Culig Z; Radmayr C; Bartsch G; Klocker H; Hittmair A
Prostate; 1996 Feb; 28(2):129-35. PubMed ID: 8604394
[TBL] [Abstract][Full Text] [Related]
5. Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma.
Magi-Galluzzi C; Montironi R; Prete E; Kwan PW; Delellis RA
Anticancer Res; 1996; 16(5A):2931-6. PubMed ID: 8917409
[TBL] [Abstract][Full Text] [Related]
6. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307
[TBL] [Abstract][Full Text] [Related]
7. Development of an optimal protocol for antigen retrieval: a 'test battery' approach exemplified with reference to the staining of retinoblastoma protein (pRB) in formalin-fixed paraffin sections.
Shi SR; Cote RJ; Yang C; Chen C; Xu HJ; Benedict WF; Taylor CR
J Pathol; 1996 Jul; 179(3):347-52. PubMed ID: 8774494
[TBL] [Abstract][Full Text] [Related]
8. Metastases of prostate cancer express estrogen receptor-beta.
Lai JS; Brown LG; True LD; Hawley SJ; Etzioni RB; Higano CS; Ho SM; Vessella RL; Corey E
Urology; 2004 Oct; 64(4):814-20. PubMed ID: 15491740
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.
Qiu YQ; Leuschner I; Braun PM
Asian J Androl; 2008 Nov; 10(6):855-63. PubMed ID: 18958349
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors.
Isola JJ
J Pathol; 1993 May; 170(1):31-5. PubMed ID: 8100853
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of androgen receptor content in advanced prostate cancer.
Magi-Galluzzi C; Xu X; Hlatky L; Hahnfeldt P; Kaplan I; Hsiao P; Chang C; Loda M
Mod Pathol; 1997 Aug; 10(8):839-45. PubMed ID: 9267828
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of androgen receptor expression in human prostate tumors and benign tissues.
Krishan A; Oppenheimer A; You W; Dubbin R; Sharma D; Lokeshwar BL
Clin Cancer Res; 2000 May; 6(5):1922-30. PubMed ID: 10815917
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor in prostate carcinoma: immunohistochemical and ligand saturation analyses.
Vagundova M; Vagunda V; Vermousek I; Rovny A
Neoplasma; 2003; 50(4):287-90. PubMed ID: 12937842
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG
J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
[TBL] [Abstract][Full Text] [Related]
18. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
19. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
20. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]